For patients with early breast cancer, breast conservation therapy results in higher patient satisfaction with equivalent or improved long-term survival compared to mastectomy ( , ). The risk of positive margins after lumpectomy, however, remains a problem. Reoperations after initial breast conservation surgery (BCS) often exceed 20%, compromising aesthetic results, driving up healthcare costs, and prolonging time to adjuvant therapy for tens of thousands of women each year.
展开▼
